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ABSTRACT
MAML1 is a transcriptional coregulator originally
identified as a Notch coactivator. MAML1 is also
reported to interact with other coregulator proteins,
such as CDK8 and p300, to modulate the activity
of Notch. We, and others, previously showed that
MAML1 recruits p300 to Notch-regulated genes
through direct interactions with the DNA–CSL–
Notch complex and p300. MAML1 interacts with
the C/H3 domain of p300, and the p300–MAML1
complex specifically acetylates lysines of histone
H3 and H4 tails in chromatin in vitro. In this
report, we show that MAML1 potentiates p300 auto-
acetylation and p300 transcriptional activation.
MAML1 directly enhances p300 HAT activity, and
this coincides with the translocation of MAML1,
p300 and acetylated histones to nuclear bodies.
INTRODUCTION
The protein Mastermind like-1 (MAML1) was cloned on
the basis of homology to the Drosophila Mastermind (1),
a neurogenic gene genetically linked to Notch function
(2–4). When the intracellular domain (ICD) of Notch
interacts with the conserved DNA-binding protein CSL
(CBF1 in vertebrates, Suppressor of Hairless in
Drosophila and Lag-1 in Caenorhabditis elegans), the
formation of a corepressor CSL complex is disrupted,
and coactivators, such as PCAF, GCN5 (5), p300 (6)
and MAML1 (7,8) are recruited. MAML1 binds to the
ankyrin (ANK) repeat region of Notch ICD, stabilizes
the interaction between Notch ICD and CSL and func-
tions as a coactivator for all four Notch receptors (1).
The MAML family comprises MAML2 and MAML3,
and all of the MAML proteins appear to function specif-
ically in Notch signaling (7,8). The highest sequence
homology among MAML proteins exists within the
N-terminal domain of MAML1, which contains two
alpha helices. This polypeptide binds CSL and Notch in
a binding pocket formed by CSL and the ANK domain
of Notch, as revealed by crystal structures of the DNA-
bound CSL–Notch–MAML1 complex (9,10). MAML1
has also been shown to function as a coactivator for
MADS box transcription enhancer factor (MEF) 2C
(11), p53 (12) and b-catenin (13).
The exact mechanism of how MAML1 functions as a
coactivator of Notch is not fully understood. However,
MAML1 has been shown to be important for recruitment
of diﬀerent coregulators, such as the histone acetyltrans-
ferase (HAT) p300 and the cyclin-dependent kinase
(CDK) 8. Recruitment of CDK8 by MAML1 leads to
phosphorylation of Notch1 and subsequent degradation
by the Fbw7/Sel10 ubiquitin ligase (14). It has previously
been reported that MAML1 potentiates Notch ICD-
mediated transcription from chromatin templates in vitro
by recruiting p300 to a DNA–CSL–Notch complex
(15,16). Moreover, MAML1 and p300 have been shown
to co-localize on the Hes1 promoter in cell culture (14).
MAML1 directly interacts with both p300 and histones,
and the p300-MAML1 complex speciﬁcally acetylates
histone H3 and H4 tails in chromatin in vitro (17). In
addition to acetylating histones, p300 also acetylates
MAML1, which requires a proline repeat motif at residues
83–90 (PAPAAPAP) in MAML1, which is conserved
between p53 (18) and MAML1 (17).
In addition to a centrally located 380-residue HAT
domain (see Figure 1A), the p300 protein contains
several well-deﬁned protein interaction domains that
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machinery with various transcription factors that bind
DNA with sequence speciﬁcity (19). This protein–DNA
interaction is further facilitated by p300 acetylation
of the transcription factors and modulation of the
chromatin structure by p300 acetylation of histones (20).
The p300 HAT domain, like that of CBP, acetylates
itself and several other domains in p300 in vitro (21–24).
Although autoacetylation, so far, has not been studied
to a similar extent as p300 acetylation of other proteins,
recent studies report that autoacetylation regulates
p300 acetyltransferase activity on histone tails and
other substrates, which modulates protein–protein inter-
actions and transcription (22,25). Interestingly, the APC/
C (anaphase-promoting complex/cyclosome) subunits
APC5 and APC7 (26), and GAPDH (glyceraldehydes-
3-phosphate dehydrogenase) (27) have been reported to
stimulate p300 autoacetylation by directly interacting
with p300.
Previous studies have shown that p300 contains a pro-
teolytically sensitive loop region (residues 1520–1560, see
Figure 1A) in the HAT domain that is conserved between
human and other mammalian homologs. This activation
loop serves an autoinhibitory function and can be mod-
iﬁed by autoacetylation of several of its lysines, which
enhances p300 HAT activity (22). The p300loop protein
(deletion of amino acids 1523–1554) functions as a more
potent coactivator for the androgen receptor as compared
with wild-type p300, further connecting this activation
loop with regulation of activity (22). In this report
we have investigated how MAML1 can inﬂuence p300
activity. We found that full-length MAML1 enhances
p300 autoacetylation in the HAT domain, which requires
the C/H3 domain of p300, but not the activation loop
of p300. We also found that full-length MAML1 potenti-
ates p300-dependent transcription coactivation, and is
even more pronounced for p300 lacking the activation
loop. Finally, we found that MAML1 enhances p300
HAT activity and this coincides with the translocation
of full-length MAML1, p300 and acetylated histones
to nuclear bodies.
MATERIALS AND METHODS
Plasmids
cDNAs encoding MAML1 1–1016, MAML1 1–625 and
MAML1 1–300 were ampliﬁed with PCR and subcloned
into pcDNA-3.1 (Invitrogen), Flag-tagged pcDNA3.1 and
pBIND (Promega) expression vectors. pCI-Flag-p300 and
pCI-Flag-p300loop (aa1523–1554) constructs were as
described previously (22). Expression plasmids CMVß-
p300-CHA and CMVß-p300-CHA-aa1737–1836 (C/H3
domain mutant) was generously provided by Dr E. Treuter
and Dr J. DeCaprio, respectively. pCI-Flag-p300HAT
(aa 1472–1522) was a gift from Dr J. Boyes and
Flag-p300HAT-C/H3 (aa 1195–1810) was a gift from Dr
R.G. Roeder. pVR1012-Gal4-p300 was generously pro-
vided by Dr N. Perkins. pcDNA3.1/myc-His-Notch1
ICD (aa 1760–2556) was a gift from Dr T. Kadesch.
Celllines
The f-MAML1 cell line was made by transfecting 293 cells
with a f-MAML1-pcDNA3.1 vector (geneticin selection).
Expression and purification of proteins
FLAG-tagged proteins for in vitro acetylation assays were
expressed in Sf9 cells via baculovirus and puriﬁed as
described previously (17).
Proteinacetylation assays
For p300 autoacetylation in vitro, 0.5mg of MAML1 pro-
teins were incubated with 50ng of p300 and 3mM
3H-acetyl-CoA in 20ml reaction volume in HAT buﬀer
(50mM Tris–HCl, pH 8.0, 50mM KCl, 5% glycerol,
0.1mM EDTA, 1mM DTT, 1mM PMSF, 10mM
sodium butyrate) at 308C for 1h, and the reaction mixture
was subjected to SDS–PAGE and autoradiography. In
addition, 2mg of FLAG-MAML1 and 1mg of FLAG-
p300 (1195–1810) were added to HAT buﬀer and 20mM
cold acetyl-CoA. The reaction mixture was incubated at
308C for 30min and acetylation of Lys1499 analyzed by
western blot.
HAT assay
In vitro HAT assays were conducted in a 30ml reaction
volume, at 0.1M HEPES, 0.2mM EDTA, 0.1mg/ml
BSA and 2mM DTT. First, a synthetic peptide of the
15N-terminal residues of histone H4 was added to
reaction tubes with peptide ﬁnal reaction concentrations
of 10 and 60mM. Puriﬁed MAML1 protein, or control
buﬀer, was added with MAML1 ﬁnal reaction concentra-
tions of 0, 100, 200 and 400nM. Recombinant full-length
p300, or control buﬀer, was added with p300 ﬁnal reaction
concentrations of 0 and 5nM. These reaction tubes
were allowed to equilibrate for 10min at 308C. Then,
14C-acetyl-CoA was added to each tube with a ﬁnal
concentration of 20mM. The reactions were allowed
to proceed for 7min at 308C, and quenched with 6mlo f
6 tricine loading buﬀer. Aliquots of each reaction were
analyzed for total radioactivity alongside a
14C-BSA
standard using a scintillation counter. Aliquots of each
reaction were analyzed for acetylation activity by separat-
ing with gel electrophoresis on a 16% Tris–tricine gel,
alongside a
14C-BSA standard, followed by quantiﬁcation
with a phosphorimager and subtraction of background.
The rate of acetylation of the H4–15 peptide was calcu-
lated in nM/min, and the low level of acetylation in the
no-p300 control for each peptide and MAML1 concentra-
tion condition subtracted. The experiment was repeated
exactly, run on a separate gel, and data from the dupli-
cates were averaged and standard deviations calculated.
Curves were ﬁt using a standard ligand–receptor inter-
action. Data at 10mM peptide were qualitatively similar
to those at 60mM peptide, however, the larger error pre-
vented a precise comparison.
Transient transfections and immunoprecipitation
293 cells were transiently transfected with 700ng
GAL4-p300, 1mg MAML1 and the reporter plasmid
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(Invitrogen). After 48h, cells were lysed in 250ml Roche
lysis buﬀer and after centrifugation the levels of luciferase
were measured. The bars in the Figures 2G, 4B and 5D
represent mean values obtained from at least three inde-
pendent experiments. For in vivo acetylation experiments,
293 cells were transiently transfected with pcDNA-
MAML1 and pCMV-p300-HA using Lipofectamine
2000 (Invitrogen) and treated with 10mM sodium buty-
rate after 32h. The cells were harvested 48h after transfec-
tion, and lysed in RIPA lysis buﬀer (25mM Tris–HCl pH
7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycholate,
0.1% SDS), and immunoprecipitation of p300 was per-
formed with an antibody recognizing the p300N-terminus
(Santa Cruz N-15) coupled to Protein A Sepharose (GE
Healthcare) following the manufacturer’s protocol. The
input and IP (immunoprecipitation) samples were ana-
lyzed by western blotting using the following antibodies:
p300 (N-15), acetylated-Lysine antibody (Cell Signaling),
MAML1 (Bethyl Laboratories), acetylated lysine 1499,
acetylated histone H3 (Ac-H3) and acetylated histone
H4 (Ac-H4) (Upstate Biotechnology), histone H3
(Abcam) and GAPDH (Ambion). For siRNA transfec-
tions we used DharmaFECT 1 siRNA reagents, and pre-
designed MAML1 SMARTpool set of 4 siRNA, from
Dharmacon.
ChIP assay
ChIP assays were performed following a modiﬁed version
of Upstate ChIP protocol. 300ng of Notch, 1mgo f
MAML1 1–1016 or 1–300, and empty vector to a ﬁnal
plasmid amount of 3mg, were transfected using TransIT-
LT1 transfection reagent (Mirus) into U2OS cells. Twenty
hours after transfection, cells were cross-linked with 1%
formaldehyde for 10min at 378C, washed two times with
ice cold PBS and lysed in 500ml NE buﬀer. The chromatin
was shared by diagenode sonication for 12min at 48C,
centrifuged at 13000r.p.m. for 10min, and diluted 10
times with dilution buﬀer. Four micrograms of Acetyl-
H3 (Upstate Biotechnology) and control IgG antibodies
(Santa Cruz Biotechnology) were used for immunopreci-
pitation. The Hes-1 or GAPDH promoter regions were
ampliﬁed with PCR (35 cycles) by sequence-speciﬁc
primers.
Immunostaining
Cos-7 cells were seeded on glass slides (Menzel-Glaser)
the day before transfection. Conﬂuent cells of 60–80%
were transfected using TransIT-LT1 transfection reagent
(Mirus) and incubated for 24h. Cells were washed (three
times for 3min, otherwise indicated) with ice-cold
PBS and ﬁxed with 4% paraformaldehyde for 20min at
48C. Cells were washed with PBS and permeabilized with
1% Triton X-100 (Sigma) in PBS at RT. Slides were
washed and blocked with 3% BSA (Sigma) in PBS
for an hour at RT. After PBS wash the slides were
incubated with primary antibodies diluted in 3% BSA
with 0.2% Triton X-100 in PBS, overnight at 48C. Next
day, slides were washed four times for 5min and incu-
bated with FITC-conjugated rabbit or Cy3-conjugated
mouse antibodies (Jackson ImmunoResearch Labora-
tories) diluted in PBS for 2h at RT. Slides were washed
four times for 5min and incubated with 0.1mg/ml DAPI
(Sigma) in PBS for 20s. After three washes with PBS,
slides were mounted with Immuno-Mount medium
(Thermo) and analyzed with ﬂuorescence microscope
coupled with AxioCam digital camera (MRm), using
Axio Vision software (Zeiss).
RESULTS
MAML1 enhances p300 autoacetylation
When we previously reported that p300 acetylates
MAML1 (17), we also noticed that in our in vitro acetyla-
tion assay p300 became more acetylated in the presence
of MAML1. To see if MAML1 increases p300 autoacety-
lation in cell culture, plasmids expressing MAML1 and
p300 or p300HAT were cotransfected into 293 cells.
Whole-cell extracts were prepared, and the p300 protein
was immunoprecipitated with a p300 antibody. p300 and
MAML1 were detected by western blotting with antibo-
dies recognizing MAML1, p300 or acetylated lysines in
p300. As shown in Figure 1B, the acetylation of p300 is
strongly enhanced in the presence of MAML1 (compare
lanes 2 and 4). Interestingly, acetylation of Lys1499, a
lysine shown to regulate p300 acetylation of histones
(22), is also increased. The p300 autoacetylation is totally
dependent on the p300 HAT domain. When the p300
protein lacks the HAT domain, there is no detectable
acetylation (Figure 1C, lanes 2 and 4), which suggests
that MAML1 itself does not acetylate p300 or recruit
other HATs.
To analyze whether MAML1 is directly responsible
for potentiating p300 autoacetylation, we performed
in vitro acetylation assays. Recombinant p300 and
MAML1 were incubated with
3H-acetyl-CoA and reac-
tion products visualized by autoradiography. Our data
show that MAML1 strongly potentiates p300 autoacety-
lation in vitro (Figure 1D, compare lanes 2 and 3). In
addition, recombinant p300 (amino acids 1195–1810)
and MAML1 were incubated with cold acetyl-CoA, and
acetylation monitored by western blotting with an anti-
body recognizing acetylation of Lys1499 in p300. As
shown in Figure 1E, acetylation of p300 Lys1499 is
strongly increased in the presence of MAML1 (compare
lanes 2 and 3).
The p300 HAT activity and coactivatorfunction
is potentiatedby MAML1
Autoacetylation of p300, including at lysine 1499, has
been shown to regulate the p300 HAT activity (22).
Therefore, we performed an in vitro HAT assay, to see if
MAML1 directly aﬀects the HAT activity. Recombinant
full-length p300, MAML1 and histone H4 tail peptide
were incubated with
14C-acetyl-CoA for 7min. The acet-
ylation reaction was quenched, separated on a Tris–tricene
gel and acetylation levels quantiﬁed with phosphoimager.
As shown in Figure 2A, MAML1 signiﬁcantly enhances
p300 acetylation of histone H4 tails, the p300 HAT
2998 Nucleic Acids Research, 2009, Vol. 37,No. 9activity is dependent on the concentration of MAML1
and the apparent Kd for MAML1 is 27060nM.
In addition, we investigated if MAML1 regulates p300
and histone acetyl-lysine localization in cell culture. Cos7
cells were cotransfected with p300-HA and FLAG-
MAML1 and immunostained with antibodies recognizing
p300, FLAG-tag and acetylated histones H4 (Figure 2B)
and H3 (Supplementary Data, Figure 2B), and in all
cases data for H4 and H3 were consistent. In the absence
of transfected MAML1, p300 is present throughout the
nucleus and histones are acetylated (Figure 2B, row 1).
In the absence of transfected p300, there are low levels
of acetylated histones in the nucleus that colocalize
with MAML1 (row 2). When cells are transfected with
both p300 and MAML1, MAML1 strongly directs acet-
ylation of histone H4 in nuclear bodies. p300, MAML1
and acetylated histones all colocalize to these nuclear
bodies (rows 3 and 4). To see if the directing of p300
to nuclear bodies by MAML1 is correlated with hypera-
cetylated (and more activated) p300, we investigated if
MAML1 confers increased acetylation of p300 Lys1499
in nuclear bodies. Vectors expressing p300-HA and
FLAG-MAML1 were cotransfected into Cos7 cells and
immunostained for acetylated p300 Lys1499. As shown
in Figure 2C, MAML1 transfection not only induces
the translocation of p300 to nuclear bodies, it also
leads to increased acetylation of Lys1499 in p300 in cell
culture.
ChIP assays were performed to examine whether acet-
ylation of histones in response to MAML1 takes place
at the promoter region of the known Notch target gene,
Hes-1. U2OS cells were transfected with Notch1 ICD
and MAML1 1–1016 or 1–300. Immunoprecipitation
was done with an antibody recognizing acetylated H3
and a control IgG antibody. Our data in Figure 2D
shows that the control IgG antibody immunoprecipitation
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Figure 1. MAML1 enhances p300 autoacetylation. (A) Schematic of p300 and MAML1 domains. (B) and (C) p300 autoacetylation is regulated by
MAML1 in vivo. Plasmids expressing p300 or p300HAT, as described in the ﬁgures, and MAML1 were cotransfected into 293 cells, whole-cell
extracts prepared, and the p300 protein was immunoprecipitated with a p300 antibody. Proteins were separated by SDS–PAGE and detection of the
p300 protein and acetylation p300, and MAML1, were monitored by western blotting with antibodies recognizing p300, MAML1 or acetylated
lysines in p300. (D) In vitro acetylation of p300. Recombinant full-length proteins of p300 and MAML1 (indicated at the top) were incubated with
3H-acetyl-CoA, and reaction products were separated by SDS–PAGE and visualized by autoradiography (top panel). Coomassie blue-stained SDS-
gel showing p300 and MAML1 proteins used in the acetylation assay (lower panel). (E) Recombinant p300 and MAML1 (indicated at the top) were
incubated with cold acetyl-CoA, and reaction products were separated by SDS–PAGE and visualized by western blotting with an antibody
recognizing acetylated Lys1499 in p300.
Nucleic Acids Research,2009, Vol.37, No. 9 2999of the endogenous Hes-1 promoter (containing two
CSL binding sites) is not visible in Notch or MAML1
(lanes 6–10) transfected cells. Anti-Acetyl-H3 precipita-
tion of the Hes-1 promoter is detectable in Notch1
ICD (lane 11) and MAML1 1–1016 (lane 14) transfected
cells and signiﬁcantly enhanced when Notch and MAML1
1–1016 are cotransfected (lane 12). Cotransfection of
Notch1 ICD and MAML1 1–300 gives an intermediate
eﬀect (lane 13). The histone H3 acetylation events at the
Hes-1 promoter are speciﬁc since the levels of acetylation
are equal at the GAPDH promoter in the absence or pres-
ence of Notch and MAML1 transfection (lanes 11–15).
These data show that HATs recruited by the Notch–
MAML1 complex acetylate H3 at speciﬁc promotor
regions at a greater level than when Notch or MAML1
are supplied alone.
After establishment of a 293 cell line that stably
expresses Flag-tagged MAML1 (f-MAML1) (Figure 2E,
lane 2), we investigated if the level of global histone
acetylation would be aﬀected in these cells. Lysates were
prepared from f-MAML1 cells and a 293 control (Ctrl)
cell line, and the levels of acetylated histones were
analyzed by western blotting with antibodies recognizing
acetylated H3 and H4. We found that acetylation of
histone H3 and histone H4 are signiﬁcantly increased
in the MAML1-expressing cell line (Figure 2E, com-
pare lanes 1 and 2), while the histones are equally
well expressed in both cell lines (see histone H3,
lanes 1 and 2). The expression level of GAPDH, which
is not a MAML1 target, is also similar in both cell
lines (lanes 1 and 2). The in vivo function of
MAML1-dependent histone acetylation was further
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Figure 2. The p300 HAT activity and coactivator function is potentiated by MAML1. (A) 5nM recombinant full-length p300, MAML1 and 60mM
synthetic histone H4N-terminal tail 15-mer peptide were allowed to pre-equilibrate for 10min, followed by a 7min reaction at 308C with 20mM
14C-acetyl-CoA. HAT reactions were separated by Tris–tricene gel electrophoresis alongside
14C-BSA, acetylation levels quantiﬁed with a phos-
phoimager, and background subtracted. This was performed in duplicate and averages are shown. The curve is calculated using the equation of a
standard binding isotherm, with apparent Kd of 27060nM and apparent maximal rate stimulation of 2.20.13-fold. (B) Vectors expressing p300
and FLAG-MAML1, as indicated in the ﬁgures, were cotransfected into Cos7 cells and after 24h the cells were immunostained with antibodies
recognizing p300, FLAG-tag and acetylated histone H4 or (C) acetylated lysine 1499 in p300. (D) U2OS cells were transfected with Notch1 ICD
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3000 Nucleic Acids Research, 2009, Vol. 37,No. 9explored in U2OS cells by using siRNA techniques.
As shown by immunoblot in Figure 2F, MAML1 expres-
sion was eﬀectively eliminated by MAML1 speciﬁc siRNA
treatment (lane 2), while the expression of histones (see
histone H3, lanes 1 and 2) or GAPDH (lanes 1 and 2)
were not aﬀected. MAML1 siRNA resulted in a signiﬁ-
cant reduction of the global histone H3 (2.7-fold)
and histone H4 (2.0-fold) acetylation level compared
to that observed with control siRNA-treated cells (com-
pare lanes 1 and 2). Since we found that MAML1
enhances p300 autoacetylation, and HAT activity, we
also investigated if MAML1 increases p300 transcrip-
tional activity of a reporter gene in cell culture. 293
cells were cotransfected with a plasmid containing ﬁve
GAL4 sites upstream of a luciferase gene and plasmids
expressing GAL4–p300 and MAML1 1–1016. The level
of transactivation by GAL4–p300 was signiﬁcantly
enhanced (20-fold) when cotransfected with MAML1
(Figure 2G).
The p300C/H3 domainregulates p300 autoacetylation
We have previously shown with an in vitro binding assay
that MAML1 interacts directly with the p300C/H3
domain (amino acids 1647–1818, see Figure 1A), suggest-
ing that this domain in p300 could be important for
the MAML1-dependent increase in p300 autoacetylation.
We therefore transfected 293 cells with MAML1 and
p300 or p300C/H3 to perform a cell culture acetylation
assay. MAML1 and p300 proteins, and acetylation of
p300, were detected by western blotting with antibodies
recognizing MAML1, p300, or acetylated lysines in p300.
We found that there is much greater autoacetylation
of p300C/H3 protein than wild-type p300 (Figure 3A,
compare lanes 2 and 4, 7 and 9). There is a robust increase
in autoacetylation of wild-type p300 in the MAML1
cotransfected cells (compare lanes 2 and 3), which is
further enhanced when the HDAC inhibitor sodium buty-
rate is included in the assay (compare lanes 7 and 8).
However, there is no MAML1-dependent increase in
autoacetylation of the p300C/H3 protein (compare
lanes 4 and 5, 9 and 10). Furthermore, we found that
p300 Lys1499 autoacetylation, which we showed above
to be activated in vitro by MAML1, is also constitutively
autoacetylated in p300C/H3. However, we could not
detect any MAML1-dependent p300 autoacetylation
at this residue in our in vivo assay (Figure 3A, row 3).
In addition, we investigated if MAML1 could aﬀect
p300C/H3 translocation in cells. FLAG-MAML1 was
cotransfected with p300-HA or p300C/H3-HA expres-
sion plasmids into Cos7 cells and after 24h the cells
were immunostained with antibodies recognizing the
HA-tag or FLAG-tag. While wild-type p300 is evenly
distributed in the nucleus (Figure 3B, row 1), and translo-
cates to nuclear bodies in the presence of MAML1,
where the two proteins colocalize (row 2), p300C/H3
is distributed in nuclear bodies regardless of MAML1
(row 3). However, coexpression of MAML1 further
enhances translocation of p300C/H3 proteins to nuclear
bodies, indicating that there could still be a functional
interaction between MAML1 and p300 without the
C/H3 domain, perhaps through another cofactor.
MAML1-dependent p300 autoacetylationis not
regulated by theactivation loopin p300
p300 has previously been shown to contain an autoinhibi-
tory activation loop which regulates the autoacetylation,
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Nucleic Acids Research,2009, Vol.37, No. 9 3001and HAT activity, of p300 (22). To see if this loop could
be involved in controlling MAML1-dependent p300
autoacetylation, 293 cells were transfected with MAML1
and wild-type p300 or p300 lacking the activation
loop (p300loop). Lysates were prepared from the cells
and the levels of MAML1, p300 and p300 acetylation
were analyzed by western blotting with antibodies recog-
nizing MAML1, p300, acetylated lysines or acetylated
Lys1499 in p300. As shown in Figure 4A, p300 appears
to be signiﬁcantly more acetylated when lacking the acti-
vation loop (compare lanes 2 and 4). However, the
MAML1-dependent increase in p300 autoacetylation is
similarly proportionately enhanced with wild-type versus
loop-deleted p300 proteins (compare lanes 2 and 3, 4
and 5). Since acetylation of p300 wild-type is greater in
the presence of MAML1 than acetylation of p300loop
in the absence of MAML1 (compare lanes 3 and 4), these
data argue that MAML1 activation of p300 autoacetyla-
tion is independent of this HAT domain regulatory loop.
Moreover, in an in vivo binding assay, MAML1 interacts
equally well with the p300 and p300loop proteins (data
not shown).
The p300loop protein has previously been shown
to function as a more potent coactivator for the androgen
receptor than wild-type p300 (22). To see if the p300loop
protein would function as a more potent coactivator of
MAML1, 293 cells were cotransfected with a luciferase
reporter containing ﬁve Gal4-binding sites and vectors
expressing Gal4-MAML1 1–1016 and wild-type p300 or
p300loop. As shown in Figure 4B, MAML1-induced
coactivation is greatly enhanced by p300loop relative
to wild-type p300. The western blot in Figure 4B
shows that the p300 proteins are equally well expressed
in 293 cells so we infer that the p300 activation
loop deletion and MAML1 synergize to stimulate
transcription.
MAML1-dependent p300autoacetylation and p300
transcriptional coactivatorfunction is optimized
by full-length MAML1 protein
Data from our ChIP assay (see Figure 2D) show that
full-length MAML1 protein, and to a lesser extent
MAML1 1–300, cooperates with Notch1 ICD to stimulate
histone H3 acetylation at the Hes-1 promoter. To investi-
gate which domains in MAML1 are required to enhance
p300 autoacetylation, we performed an in vitro acetylation
assay, where recombinant MAML1 proteins were incu-
bated with p300 and
3H-acetyl-CoA. The full-length
MAML1 1–1016 protein strongly enhances p300 autoace-
tylation (Figure 5A, compare lanes 1 and 2), while
MAML1 1–300, 309–625, 499–804 and 701–1016 are not
suﬃcient to stimulate autoacetylation (lanes 3–6).
We next investigated whether full-length MAML1
protein is required to increase p300 autoacetylation in
cell culture. 293 cells were transfected with p300 together
with MAML1 1–1016, 1–625 or 1–300. Acetylated p300
was detected by western blotting with an antibody recog-
nizing acetylated Lys1499 in p300. As shown in Figure 5B,
the autoacetylation of p300 is strongly enhanced in the
presence of MAML1 1–1016 (compare lanes 2 and 3), to
a lesser extent in the presence of MAML1 1–625 (lane 4),
and not signiﬁcantly by MAML1 1–300 (lane 5). In
addition, Cos7 cells were transfected with p300-HA
and FLAG-MAML1, to determine which MAML1
domains modulate histone acetylation in nuclear bodies
by p300 in cell culture. Immunostaining of the cells
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acetylated histone H3 shows that MAML1 1–1016
induces the relocation of histone acetylation to nuclear
bodies (Figure 5C, row 1), whereas MAML1 1–625
(rows 2 and 3) and MAML1 1–300 (rows 4 and 5)
fails to do so. To investigate if MAML1 full length is
needed to aﬀect p300 transcriptional activity in cell cul-
ture, plasmids expressing Gal4-p300 and various MAML1
domains were cotransfected with a luciferase reporter into
293 cells. As shown in Figure 5D, MAML1 1–1016
strongly enhances p300 transcriptional coactivation,
while MAML1 1–625 only moderately enhances p300
activity. MAML1 1–300 does not contribute signiﬁcantly
to p300 activation.
DISCUSSION
p300 has previously been reported to enhance transcrip-
tional activation for various activators, and to work in
synergy with MAML1 in Notch-mediated transcription
(15,16). We show in this report that MAML1 enhances
p300 activity, and have investigated the molecular
mechanisms and function for this interplay. When we
previously reported that p300 acetylates MAML1 (17),
we also noticed that p300 became more acetylated in the
presence of MAML1. In our in vitro acetylation assay,
MAML1 does not seem to have any intrinsic acetyltrans-
ferase activity (data not shown). However, the p300
protein has been shown to undergo autoacetylation (22).
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MAML1-dependent increase in p300 autoacetylation is
totally dependent on the HAT domain of p300.
MAML1 has previously been shown to stimulate trans-
location of p300 to nuclear bodies (16). Nuclear bodies
are punctuate structures found in the nuclei of certain
cells, and they are suggested to be involved in a variety
of cellular functions, such as transcriptional regulation
and chromatin organization, post-translational modiﬁca-
tions of proteins and identiﬁcation and storage of pro-
teins (28). Consistently, we show that in the presence of
MAML1, p300, acetylated histones and MAML1 itself
colocalize to nuclear bodies. The levels of p300 autoace-
tylation have been shown to correlate with p300 HAT
activity, in particular autoacetylation of Lys1499 appears
to stimulate p300 acetylation of histones (22). We provide
evidence that MAML1-enhanced p300 autoacetylation,
which includes acetylation of Lys1499, leads to an increase
in p300 HAT activity in vitro. MAML1 directs p300-
dependent acetylation of histone H3 and H4 in nuclear
bodies, and acetylation of Lys1499 in p300 is higher in
the nuclear bodies in the presence of MAML1. Thus,
our data suggest that the nuclear bodies might be impor-
tant for p300 modiﬁcation by acetylation, and perhaps
storage of a pool of acetylated, and active, p300. It
remains, however, to be investigated if transcription of
p300-regulated genes also occurs in the nuclear bodies.
The MAML1 protein contains various domains, and
the N-terminal domain interacts with p300. We found
that MAML1 1–625 increases p300 autoacetylation,
although not as strongly as MAML1 1–1016, suggesting
that multiple domains between residues 300–1016 in
MAML1 are important for p300 autoacetylation.
However, our data show that only MAML1 full length,
and none of the truncated MAML1 proteins tested,
including amino acids 1–300 and 1–625, is suﬃcient
to fully potentiate p300-dependent transcription coactiva-
tion and to direct histone acetylation to nuclear bodies.
This data is consistent with a previous report by Fryer
et al. describing that full-length MAML1 induces trans-
location of p300 to nuclear bodies, and it was suggested
that the MAML1 protein contains a C-terminal region
that is important for in vivo transcriptional activation
(16). This latter point is supported by our observation
that in cell culture, full-length MAML1 enhances Notch-
dependent histone acetylation at a promotor region to a
greater extent than does MAML1 1–300.
p300 has previously been shown to contain an auto-
inhibitory loop that regulates acetylation, and activity,
of p300 (22). We conﬁrm here that p300 shows increased
acetylation when lacking this activation loop. We also
found that, in cell culture, MAML1 potentiates p300-
dependent transcription coactivation to a greater extent
when p300 lacks the activation loop. However, the
MAML1-dependent increase in p300 autoacetylation is
not dependent on the loop, which suggests that other
domains in p300 can function as targets for regulating
p300 activity. We have previously mapped MAML1 bind-
ing to p300C/H3 domain in p300 (17). The C/H3 domain
is adjacent to the p300 HAT domain, and a potential
domain for regulating HAT activity. It is possible that
the C/H3 domain may interact with the negatively charged
HAT surface through electrostatic interactions as pro-
posed for the p300 activation loop (29). In this article
we describe that autoacetylation of p300C/H3 is
enhanced versus wild-type p300, and its ability to localize
to nuclear bodies is facilitated relative to p300 wild-type.
Furthermore, without the C/H3 domain, p300 is auto-
acetylated independently of MAML1. The mechanism
behind this is not clear, but these observations suggest
that a corepressor might interact with the C/H3 domain.
For example, HDAC1 has been reported to bind to the
p300C/H3 domain (30). It is possible that MAML1 bind-
ing to the C/H3 domain, relieves the corepressor, which
leads to enhanced p300 activity. Another theory is that
there is no corepressor interacting at the C/H3 domain,
but rather MAML1 binding to C/H3 induces a conforma-
tional change in the HAT and/or C/H3 domains, which
do not aﬀect the autoinhibitory loop, but activates p300.
In our in vitro acetylation assay, recombinant Flag-
MAML1 enhances autoacetylation (Lys1499) of recombi-
nant p300 (Flag-HAT-C/H3) aﬃnity-puriﬁed from
Escherichia coli. Moreover, Kraus and collaborators
showed with aﬃnity-puriﬁed recombinant proteins in an
in vitro acetylation assay, that deletion of the C/H3
domain leads to a strong increase in HAT activity (23).
Their, and our, data supports the model that it is rather
the C/H3 domain itself that represses the p300 HAT
activity, and its inhibitory eﬀect can be relieved by inter-
actions with other proteins. It is not clear how the
p300C/H3 protein translocates to the nucleus by itself,
if autoacetylation per se is suﬃcient for nuclear body
translocation, and how MAML1 can stimulate this trans-
location. We speculate that a functional interaction might
exist between MAML1 and p300 without the C/H3
domain, perhaps through multiple MAML1 binding
sites in p300, or through yet another cofactor.
p300 autoacetylation might play a role in recruitment
of coregulator proteins to a promoter, acetylation of his-
tones to modulate chromatin structure, pre-initiation
(PIC) assembly, transcriptional elongation and promoter
clearance. The increased p300 transcriptional coactivation
observed in the presence of MAML1, when autoacety-
lation of the p300 HAT domain is increased, is probably
due at least in part to increased acetylation of histones.
It has been demonstrated that acetylation of p300 leads to
a conformational change that removes the autoinhibitory
loop resulting in enhanced HAT activity (22). It could
be possible that MAML1 binding might induce a similar
conformational change.
It is also possible that the MAML1-dependent increase
in p300 autoacetylation leads to p300 dissociation from
promoter regions. We have previously shown that p300
binds less strongly to MAML1 in the presence of acetyl-
CoA, which could be due to acetylation of MAML1 or
increased p300 autoacetylation (17). We also reported pre-
viously that MAML1 can bind to histone tails in vitro
(17) and speculated that the previously described p300
interaction with histone tails (31) might be important
for the p300 coactivator function at Notch-regulated pro-
moters. By using deﬁned in vitro assays, Black and collea-
gues showed that (i) autoacetylation of p300 causes it to
3004 Nucleic Acids Research, 2009, Vol. 37,No. 9dissociate from GAL4–VP16–Mediator complex (ii) pre-
acetylated p300 does not bind to GAL4-VP16-Mediator
complexes and (iii) inhibition of the p300 HAT activity
prevents p300 from dissociation. They concluded that
transcription requires dissociation of p300, and reported
that p300 dissociates from a tetracycline-inducible,
VP16-responsive promoter in vivo prior to accumulation
of transcript, and suggested the possibility that auto-
acetylation of p300 is controlling the dissociation also
in vivo (32).
Black and colleagues also provided evidence that p300
autoacetylation regulates the competitive binding between
p300 and TFIID to the Mediator complex, and showed
that increased recruitment of p300 in the presence of
Mediator resulted in elevated histone acetylation (32).
Their data is consistent with previous reports describing
a cooperative eﬀect in transcription between Mediator and
p300 on chromatin templates in vitro activated by HNF4a
(33), PPARg (34) and ERa (35). MAML1 has been shown
to directly interact with the CDK8 kinase, a subunit in the
Mediator complex (16), and MAML1 stimulates tran-
scription from DNA templates (15), suggesting that
MAML1 binds to the Mediator complex. MAML1
might, through direct interactions with both p300 and
Mediator, coordinate the recruitment of these cofactors
to promoter regions. Thus, MAML1 may stimulate p300
autoacetylation so that p300 can dissociate from a pro-
moter region and Mediator can then be recruited by
MAML1. We have previously hypothesized that it is the
p300-interacting proteins that determine the acetylation
pattern of histones (17). Based on our new data and
from other studies, it seems clear that interacting proteins
can regulate p300 activity by controlling p300 autoacety-
lation. Future directions will focus on investigating the
speciﬁcity in timing and termination of MAML1
enhanced p300 autoacetylation.
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